PEGYLATED LIPOSOMES FOR DELIVERY OF RNA ENCODING AN IMMUNOGEN

CY1125995T1Undetermined Publication Date: 2026-07-31GLAXOSMITHKLINE BIOLOGICALS SA
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CY20231100118T
Authority / Receiving Office
CY · CY
Patent Type
Patents
Current Assignee / Owner
Priority Date
2010-08-31
Filing Date
2023-03-03
Publication Date
2026-07-31
Estimated Expiration
2043-03-03
Patent Text Reader

Abstract

Immunization with nucleic acid is achieved by administering RNA encapsulated within a pegylated liposome. The RNA encodes an immunogen of interest. The PEG has an average molecular mass of between 1 kDa and 3 kDa. Accordingly, the invention provides a liposome having a lipid bilayer encapsulating an aqueous core, wherein: (i) the lipid bilayer comprises at least one lipid containing a polyethylene glycol moiety, such that the polyethylene glycol is on the exterior of the liposome, wherein the average molecular mass of the polyethylene glycol is between 1 kDa and 3 kDa, and (ii) the aqueous core contains an RNA encoding an immunogen. These liposomes are suitable for in vivo delivery of the RNA to a vertebrate cell and are therefore useful as components of pharmaceutical compositions for immunizing individuals against various diseases.
Need to check novelty before this filing date? Find Prior Art